|
- Brand:NO
- Model:1G,10G,1KG,5KG,25KG
- Purity:98%
- Cas:86168-78-7
- Createtime: 2026-07-02
- Updatetime: 2026-07-16
| useage | FOR R&D RESEARCH USE |
| deliveryInfo | |
| appearance | white to off white powder |
| aliasen | |
| supplyCapacity | 5000000KG/Year |
| harbor | SHENZHEN |
| minorder | 1G |
1. Core Product Specifications
Product Name: Sermorelin
Chinese Name: Sermorelin
CAS No.: 86168-78-7
Peptide Type: Synthetic growth hormone-releasing peptide (GHRH fragment), endocrine regulatory peptide, pharmaceutical intermediate, scientific research biochemical reagent
Molecular Formula: C???H???N??O??S
Molecular Weight: 3357.89 Da
Appearance: White to off-white lyophilized crystalline powder, uniform loose texture, non-caking, odorless with ultra-low impurities
Purity: ≥98.0% (HPLC, research grade / pharmaceutical grade)
Form: Free peptide, standard commercial stable specification
Moisture Content: ≤2.0%
Heavy Metals: ≤10ppm
Endotoxin: ≤0.1EU/mg
Residue on Ignition: ≤0.1%
Solubility: Freely soluble in sterile water, normal saline and weakly acidic buffer solutions, forming clear, stable and precipitate-free solutions
Transport Condition: Sealed, dry and light-proof transportation at room temperature
Storage Condition: Long-term dry powder storage at -20℃ in sealed, dry and dark environment; short-term storage at 2–8℃. Dissolved solutions must be aliquoted and frozen. Strictly avoid repeated freeze-thaw cycles to prevent activity attenuation
Production Technology: Standard solid-phase peptide synthesis (SPPS), full-length precise sequence assembly, multi-stage high-precision HPLC purification, low-temperature vacuum freeze-drying activity locking technology
Core Bioactivity: Stimulate growth hormone secretion, regulate endocrine metabolism, promote cell growth and repair, improve body development and metabolic balance, anti-aging regulation
Shelf Life: 24 months for sealed dry powder stored at -20℃ under standard conditions
Usage Restriction: For scientific research, endocrine pharmacological experiments and preclinical pharmaceutical development only. Strictly prohibited for human clinical treatment, illegal preparation and application
